A large US base Pharma Company, wanted DelveInsight to support them by providing a detailed CAR-TCR Summit coverage of novel CAR-T Cell Therapies for the B-Cell Malignancies, including the emerging product analysis, developmental activities, safety and efficacy data, product milestones, future plans and KOL insights.